Leica Microsystems

Abcam appoints Markus Lusser as new President

Retrieved on: 
Monday, March 18, 2024

CAMBRIDGE, England, March 18, 2024 /PRNewswire/ -- Abcam today announced the appointment of Markus Lusser as President.

Key Points: 
  • CAMBRIDGE, England, March 18, 2024 /PRNewswire/ -- Abcam today announced the appointment of Markus Lusser as President.
  • A seasoned Danaher executive, Markus joins Abcam at a pivotal moment as the company transitions into the Danaher Life Sciences portfolio.
  • Prior to joining Danaher, Markus was responsible for large global commercial organizations, including 20 years at Siemens Healthineers.
  • As an experienced people leader, Markus is passionate about building and developing the skills and experience of his cross-functional teams.

Abcam appoints Markus Lusser as new President

Retrieved on: 
Monday, March 18, 2024

CAMBRIDGE, England, March 18, 2024 /PRNewswire/ -- Abcam today announced the appointment of Markus Lusser as President.

Key Points: 
  • CAMBRIDGE, England, March 18, 2024 /PRNewswire/ -- Abcam today announced the appointment of Markus Lusser as President.
  • A seasoned Danaher executive, Markus joins Abcam at a pivotal moment as the company transitions into the Danaher Life Sciences portfolio.
  • Prior to joining Danaher, Markus was responsible for large global commercial organizations, including 20 years at Siemens Healthineers.
  • As an experienced people leader, Markus is passionate about building and developing the skills and experience of his cross-functional teams.

Danaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform Solution

Retrieved on: 
Tuesday, January 9, 2024

The center, known as the Danaher-IGI Beacon for CRISPR Cures, aims to use CRISPR-based gene editing to permanently address hundreds of diseases with a unified research, development and regulatory approach.

Key Points: 
  • The center, known as the Danaher-IGI Beacon for CRISPR Cures, aims to use CRISPR-based gene editing to permanently address hundreds of diseases with a unified research, development and regulatory approach.
  • The collaboration, which enables a substantial new research program at IGI, is the largest Danaher Beacon to date.
  • The Beacons program funds pioneering academic research with the goal of developing innovative technologies and applications for human health.
  • The unique nature of CRISPR makes it ideal for developing and deploying a platform capability for CRISPR cures on demand.

Diagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors

Retrieved on: 
Monday, August 28, 2023

"I'm excited to join Biomerica's Board and contribute to the launch and growth of the company’s groundbreaking product, inFoods® IBS.

Key Points: 
  • "I'm excited to join Biomerica's Board and contribute to the launch and growth of the company’s groundbreaking product, inFoods® IBS.
  • As I take on my role within Biomerica's board, I'm eagerly looking forward to close collaboration with the management team.
  • “Jack brings a wealth of commercial experience and relationships in the medical diagnostic industry.
  • Throughout his career, Mr. Kenny has held additional leadership positions of increasing responsibility including key roles at Leica Microsystems, Quest Diagnostics and Bayer Diagnostics.

North America Leads the Global Logistics Automation Market with $13.2 Billion in Revenue, Asia-Pacific to Experience High Growth

Retrieved on: 
Thursday, July 20, 2023

The report offers a comprehensive overview of the global logistics automation market, analyzing its size, key trends, growth drivers, challenges, and competitive landscape.

Key Points: 
  • The report offers a comprehensive overview of the global logistics automation market, analyzing its size, key trends, growth drivers, challenges, and competitive landscape.
  • The global logistics automation market has witnessed significant growth in recent years, driven by the increasing demand for efficient and streamlined supply chain operations.
  • North America leads the global logistics automation market, with a significant share attributed to the presence of leading global companies and advanced technology infrastructure.
  • It also provides a detailed analysis of major growth drivers, challenges, technology updates, and macroeconomic variables influencing the logistics automation market.

Global Logistics Automation Market Set to Reach $64.2 Billion by 2028, Driven by Robotics and AI Technologies - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 20, 2023

The report offers a comprehensive overview of the global logistics automation market, analyzing its size, key trends, growth drivers, challenges, and competitive landscape.

Key Points: 
  • The report offers a comprehensive overview of the global logistics automation market, analyzing its size, key trends, growth drivers, challenges, and competitive landscape.
  • The global logistics automation market has witnessed significant growth in recent years, driven by the increasing demand for efficient and streamlined supply chain operations.
  • Key Findings of the Report:
    Market Size and Revenue Forecast: The global logistics automation market was valued at $33.1 billion in 2022.
  • It also provides a detailed analysis of major growth drivers, challenges, technology updates, and macroeconomic variables influencing the logistics automation market.

Quantum-Si Appoints Life Sciences and Diagnostics Industry Leader Jack Kenny to its Board of Directors

Retrieved on: 
Monday, May 22, 2023

Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Jack Kenny, CEO of Meridian Bioscience, Inc., to its Board of Directors.

Key Points: 
  • Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Jack Kenny, CEO of Meridian Bioscience, Inc., to its Board of Directors.
  • View the full release here: https://www.businesswire.com/news/home/20230522005246/en/
    “Jack brings a wealth of experience in commercial and operational leadership.
  • He has a proven track record of driving growth at Meridian Bioscience as CEO and also serves on its board of directors.
  • Throughout his career, Mr. Kenny has held additional leadership positions of increasing responsibility for companies including Leica Microsystems, Quest Diagnostics and Bayer Diagnostics.

Bruno Rossi joins Olink as Chief Commercial Officer

Retrieved on: 
Tuesday, March 21, 2023

UPPSALA, Sweden, March 21, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the appointment of life sciences industry veteran Bruno Rossi to the role of Chief Commercial Officer (CCO), effective immediately.

Key Points: 
  • UPPSALA, Sweden, March 21, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the appointment of life sciences industry veteran Bruno Rossi to the role of Chief Commercial Officer (CCO), effective immediately.
  • Mr. Rossi will lead the Company’s global commercial organization including Sales, Marketing and Sales Operations.
  • “I am delighted to welcome Bruno to the Olink organization, and look forward to the value his considerable industry experience will add to our rapidly growing company.” said Carl Raimond, President of Olink.
  • “With its best-in-class technology, leading commercial organization, and tremendous talent, Olink has positioned itself as a major force within the next-generation proteomics market,” said Bruno Rossi, CCO of Olink.

Angstrom Technology Appoints Tom Chowaniec as New Global CEO

Retrieved on: 
Tuesday, March 14, 2023

GRAND RAPIDS, Mich., March 14, 2023 /PRNewswire/ -- Angstrom Technology, a global cleanroom engineering company and portfolio company of ASGARD Partners & Co., welcomed Tom Chowaniec as its new Global CEO.

Key Points: 
  • GRAND RAPIDS, Mich., March 14, 2023 /PRNewswire/ -- Angstrom Technology, a global cleanroom engineering company and portfolio company of ASGARD Partners & Co., welcomed Tom Chowaniec as its new Global CEO.
  • Angstrom Technology, a global cleanroom engineering company, welcomed Tom Chowaniec as its new Global CEO.
  • Chowaniec comes to Angstrom Technology with over 30 years of professional experience leading global sales and service teams at GE Healthcare, Cardinal Health, Leica Microsystems and Agiliti Health.
  • "We are excited to welcome Tom to our global group of cleanroom companies," said Matt Isard, CEO of Angstrom Technology.

Optical Imaging Market worth $2.9 billion | MarketsandMarkets

Retrieved on: 
Monday, February 27, 2023

Key Points: 
  • Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=894
    Cost Effective: Optical imaging technology is relatively cost-effective compared to other imaging modalities, making it a great choice for many medical facilities.
  • Non-Invasive: Optical imaging is non-invasive and does not require any radiation exposure, which makes it suitable for imaging delicate organs and tissues.
  • Optical Imaging Market- Report Highlights:
    Refinement in the segments of the global optical imaging market:
    The current edition of the report consists of an updated market overview, average selling price trends, value chain analysis, Porter's Five Forces analysis, ecosystem map, pricing analysis, patent analysis, and new industry insights.
  • The report also consists of the impact of recession on the global optical imaging market.